echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > What should I do if the patient has clinical rash and diarrhea during the use of Osimertinib?

    What should I do if the patient has clinical rash and diarrhea during the use of Osimertinib?

    • Last Update: 2021-08-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    "Metz Live Class: Lung Cancer Diagnosis and Treatment Training Camp-Progress in Targeted Therapy of Lung Cancer in 2021"

    Diagnosis and treatment

    Answer question 2: I have just come into contact with the use of oscitinib, may I have a clinical rash during the treatment period, with obvious diarrhea, can the dosage be reduced by 80 mg once every two days or 40 mg once a day?

     

    Likes, comments, and shares are welcome

    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.